Adam Johnson

• Vivani Medical in its $75 million at-the-market offering
• The exclusive placement agent in Acrivon Therapeutic’s $130 million private placement
• Akero Therapeutics in connection with its $366.9 million upsized public follow-on offering
• Vivani Medical in its $15 million registered direct offering
• BofA Securities and BITG as placement agents in Outlook Therapeutics, Inc.’s $60 million PIPE
• The underwriters in Acrivon Therapeutics’ $100 million at-the-market offering
• ProMIS Neurosciences in its $25 million at-the-market offering
• Rapid Micro Biosystems in its $10 million at-the-market offering
• Medicxi Ventures in its purchase of $30 million worth of common stock in Phatham Pharmaceuticals in a secondary sale from Takeda Pharmaceutical Company Limited
• The underwriters in Spero Therapeutics’ $77 million initial public offering and $75 million follow-on offering*
• Evelo Biosciences in its $85 million initial public offering*
• Atea Pharmaceuticals in its $300 million initial public offering*
• The underwriters in Sigilon Therapeutics’ $126 million initial public offering*
• The underwriters in Fusion Pharmaceuticals’ $212.5 million initial public offering*

*Denotes experience prior to joining Goodwin.

• The underwriters in PACS Group $450 million initial public offering
• MeridianLink, Inc. in its $44 million public offering
• Shift4 Payments in its $345 million initial public offering, $485 million follow-on offering and $495 million secondary transaction*
• Mister Car Wash in its $562.5 million initial public offering*
• Endeavor Group Holdings in its $511.3 million initial public offering and concurrent acquisition of the UFC*
• The UFC in its $21.4 billion merger with WWE and creation of TKO Holdings*
• Solo Stove in its $59.35 million follow-on offering*

*Denotes experience prior to joining Goodwin.